1
|
Monnot M, Ollivier J, Taligrot H, Garry P, Cordier C, Stravakakis C, Le Guyader FS, Moulin P. Retention of Virus Versus Surrogate, by Ultrafiltration in Seawater: Case Study of Norovirus Versus Tulane. Food Environ Virol 2024; 16:14-24. [PMID: 38184502 DOI: 10.1007/s12560-023-09574-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Accepted: 11/28/2023] [Indexed: 01/08/2024]
Abstract
In the field of chemical engineering and water treatment, the study of viruses, included surrogates, is well documented. Often, surrogates are used to study viruses and their behavior because they can be produced in larger quantities in safer conditions and are easier to handle. In fact, surrogates allow studying microorganisms which are non-infectious to humans but share some properties similar to pathogenic viruses: structure, composition, morphology, and size. Human noroviruses, recognized as the leading cause of epidemics and sporadic cases of gastroenteritis across all age groups, may be mimicked by the Tulane virus. The objectives of this work were to study (i) the ultrafiltration of Tulane virus and norovirus to validate that Tulane virus can be used as a surrogate for norovirus in water treatment process and (ii) the retention of norovirus and the surrogate as a function of water quality to better understand the use of the latter pathogenic viruses. Ultrafiltration tests showed significant logarithmic reduction values (LRV) in viral RNA: around 2.5 for global LRV (i.e., based on the initial and permeate average concentrations) and between 2 and 6 for average LRV (i.e., retention rate considering the increase of viral concentration in the retentate), both for norovirus and the surrogate Tulane virus. Higher reduction rates (from 2 to 6 log genome copies) are obtained for higher initial concentrations (from 101 to 107 genome copies per mL) due to virus aggregation in membrane lumen. Tulane virus appears to be a good surrogate for norovirus retention by membrane processes.
Collapse
Affiliation(s)
- M Monnot
- Aix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europôle de l'Arbois, Pavillon Laennec, Hall C, BP80, 13545, Aix-en-Provence, France
| | - J Ollivier
- Ifremer - U. Microbiologie, Aliment, Santé et Environnement (LSEM/RBE), Rue de l'Ile d'Yeu, BP 21105, 44311, Nantes, Cedex 3, France
| | - H Taligrot
- Aix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europôle de l'Arbois, Pavillon Laennec, Hall C, BP80, 13545, Aix-en-Provence, France
| | - P Garry
- Ifremer - U. Microbiologie, Aliment, Santé et Environnement (LSEM/RBE), Rue de l'Ile d'Yeu, BP 21105, 44311, Nantes, Cedex 3, France
| | - C Cordier
- Aix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europôle de l'Arbois, Pavillon Laennec, Hall C, BP80, 13545, Aix-en-Provence, France
| | - C Stravakakis
- Ifremer - EMMA Plateforme Expérimentale Mollusques Marins Atlantique, 85230, Bouin, France
| | - F S Le Guyader
- Ifremer - U. Microbiologie, Aliment, Santé et Environnement (LSEM/RBE), Rue de l'Ile d'Yeu, BP 21105, 44311, Nantes, Cedex 3, France
| | - P Moulin
- Aix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europôle de l'Arbois, Pavillon Laennec, Hall C, BP80, 13545, Aix-en-Provence, France.
| |
Collapse
|
2
|
Catapano F, El Hachmi M, Ketterer-Heng N, Renieri A, Mari F, Morris M, Cordier C. Correction: The role of the genetic counsellor in the multidisciplinary team: the perception of geneticists in Europe. Eur J Hum Genet 2024; 32:133. [PMID: 36755106 PMCID: PMC10772065 DOI: 10.1038/s41431-023-01289-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023] Open
Affiliation(s)
- Francesca Catapano
- Medical Genetics, University of Siena, Siena, Italy.
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland.
| | - Mohamed El Hachmi
- Medical Genetics, University of Siena, Siena, Italy
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| | | | - Alessandra Renieri
- Medical Genetics, University of Siena, Siena, Italy
- Medical Genetics, Azienda Ospedaliera Universitaria Senese, Siena, Italy
| | - Francesca Mari
- Medical Genetics, University of Siena, Siena, Italy
- Medical Genetics, Azienda Ospedaliera Universitaria Senese, Siena, Italy
| | - Michael Morris
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| | - Christophe Cordier
- Medical Genetics, University of Siena, Siena, Italy
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| |
Collapse
|
3
|
Ould Bouamama N, Bouleau J, Cordier C, Deleplancque AS, Labalette P. [Subcutaneous loiasis rocking in the upper eyelids, a case report]. J Fr Ophtalmol 2023; 46:e201-e202. [PMID: 37100714 DOI: 10.1016/j.jfo.2023.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 12/31/2022] [Accepted: 01/02/2023] [Indexed: 04/28/2023]
Affiliation(s)
- N Ould Bouamama
- Service d'Ophtalmologie du Centre Hospitalier Universaire de Lille, 2, avenue Oscar Lambret, Lille, 59000.
| | - J Bouleau
- Service d'Ophtalmologie du Centre Hospitalier Universaire de Lille, 2, avenue Oscar Lambret, Lille, 59000
| | - C Cordier
- Service de parasitologie et mycologie du Centre Hospitalier Universitaire de Lille, 2, avenue Oscar Lambret, Lille, 59000
| | - A S Deleplancque
- Service de microbiologie du Centre Hospitalier Universitaire de Lille, 2, avenue Oscar Lambret, 59000 Lille, France
| | - P Labalette
- Service d'Ophtalmologie du Centre Hospitalier Universaire de Lille, 2, avenue Oscar Lambret, Lille, 59000
| |
Collapse
|
4
|
Paneque M, Guimarães L, Bengoa J, Pasalodos S, Cordier C, Esteban I, Lemos C, Moldovan R, Serra-Juhé C. An European overview of genetic counselling supervision provision. Eur J Med Genet 2023; 66:104710. [PMID: 36731744 DOI: 10.1016/j.ejmg.2023.104710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 12/28/2022] [Accepted: 01/22/2023] [Indexed: 02/03/2023]
Abstract
Genetic testing is becoming more commonplace in general and specialist health care, and should always be accompanied by genetic counselling, according to legislation in many European countries and recommendations by professional bodies. Personal and professional competence is necessary to provide safe and effective genetic counselling. Clinical and counselling supervision of genetics healthcare practitioners plays a key role in quality assurance, providing a safe environment not only for patients but for professionals too. However, in many European countries, genetic counsellors are still an emerging professional group and counselling supervision is not routinely offered and there are no enough evidences on the impact of these insufficiencies. This study aimed to explore the current status of genetic counselling supervision provision across Europe and to ascertain factors that might be relevant for the successful implementation of counselling supervision. A total of 100 practitioners responded to an online survey; respondents were from 18 countries, with the majority working in France (27%) and Spain (17%). Only 34 participants reported having access to genetic counselling supervision. Country of origin, the existence of a regulation system and years of experience were factors identified as relevant, influencing access and characteristics of counselling supervision. Although there is a growing number of genetic counsellors trained at European level, just a few countries have implemented and required as mandatory the access to genetic counselling supervision. Nevertheless, this is essential to ensure a safe and effective genetic counselling and should be regulated at the European genetic healthcare services.
Collapse
Affiliation(s)
- Milena Paneque
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; CGPP - Centro de Genética Preditiva e Preventiva, IBMC - Instituto de Biologia Molecular e Celular, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
| | - Lídia Guimarães
- Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; AAJUDE - Associação de Apoio à Juventude Deficiente, Portugal
| | | | - Sara Pasalodos
- Department of Medical Genetics, Complejo Hospitalario de Navarra, Universidad Publica de Navarra (UPNA), Navarra-biomed-IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra, Spain
| | | | - Irene Esteban
- Clinical Genetics Department, Queen Elizabeth University Hospital. Glasgow, Scotland, United Kingdom
| | - Carolina Lemos
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - Ramona Moldovan
- Department of Psychology, Babeş-Bolyai University, Romania; Division of Evolution and Genomic Sciences, University of Manchester, United Kingdom, Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, UK
| | - Clara Serra-Juhé
- Genetics Department, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, 08041, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Spain
| |
Collapse
|
5
|
Montgomery PC, Flury M, Anstotz F, Marbach S, Cordier C, Bartringer J, Mukhtar H, Leong-Hoï A, Rubin A, Shpiruk A, Del Nero M, Barillon R. Characterization of Functional Materials Using Coherence Scanning Interferometry and Environmental Chambers. ACS Omega 2023; 8:10643-10655. [PMID: 37008104 PMCID: PMC10061652 DOI: 10.1021/acsomega.2c07007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Accepted: 02/28/2023] [Indexed: 06/19/2023]
Abstract
Functional materials are challenging to characterize because of the presence of small structures and inhomogeneous materials. If interference microscopy was initially developed for use for the optical profilometry of homogeneous, static surfaces, it has since been considerably improved in its capacity to measure a greater variety of samples and parameters. This review presents our own contributions to extending the usefulness of interference microscopy. For example, 4D microscopy allows real-time topographic measurement of moving or changing surfaces. High-resolution tomography can be used to characterize transparent layers; local spectroscopy allows the measurement of local optical properties; and glass microspheres improve the lateral resolution of measurements. Environmental chambers have been particularly useful in three specific applications. The first one controls the pressure, temperature, and humidity for measuring the mechanical properties of ultrathin polymer films; the second controls automatically the deposition of microdroplets for measuring the drying properties of polymers; and the third one employs an immersion system for studying changes in colloidal layers immersed in water in the presence of pollutants. The results of each system and technique demonstrate that interference microscopy can be used for more fully characterizing the small structures and inhomogeneous materials typically found in functional materials.
Collapse
Affiliation(s)
- Paul C. Montgomery
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Manuel Flury
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Freddy Anstotz
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Sébastien Marbach
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Christophe Cordier
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Jérémy Bartringer
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Husneni Mukhtar
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Audrey Leong-Hoï
- Laboratoire
des Sciences de l’Ingénieur de l’Informatique
et de l’Imagerie (ICube), University
of Strasbourg - CNRS − INSA, 300 Boulevard Sébastien Brant, Illkirch 67412, France
| | - Anne Rubin
- Institut
Charles Sadron (ICS), CNRS, 23 rue du Loess, Strasbourg 67034, France
| | - Anastasiia Shpiruk
- Institut
Charles Sadron (ICS), CNRS, 23 rue du Loess, Strasbourg 67034, France
| | - Mireille Del Nero
- Institut
Pluridisciplinaire Hubert Curien (IPHC), CNRS - University of Strasbourg, 23 rue du Loess, Strasbourg 67037, France
| | - Rémi Barillon
- Institut
Pluridisciplinaire Hubert Curien (IPHC), CNRS - University of Strasbourg, 23 rue du Loess, Strasbourg 67037, France
| |
Collapse
|
6
|
Chevarin M, Alcantara D, Albuisson J, Collonge-Rame MA, Populaire C, Selmani Z, Baurand A, Sawka C, Bertolone G, Callier P, Duffourd Y, Jonveaux P, Bignon YJ, Coupier I, Cornelis F, Cordier C, Mozelle-Nivoix M, Rivière JB, Kuentz P, Thauvin C, Boidot R, Ghiringhelli F, O'Driscoll M, Faivre L, Nambot S. The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles. Oncotarget 2023; 14:111-125. [PMID: 36749285 PMCID: PMC9904323 DOI: 10.18632/oncotarget.28358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 01/23/2023] [Indexed: 02/08/2023] Open
Abstract
In oncogenetics, some patients could be considered as "extreme phenotypes", such as those with very early onset presentation or multiple primary malignancies, unusually high numbers of cancers of the same spectrum or rare cancer types in the same parental branch. For these cases, a genetic predisposition is very likely, but classical candidate gene panel analyses often and frustratingly remains negative. In the framework of the EX2TRICAN project, exploring unresolved extreme cancer phenotypes, we applied exome sequencing on rare familial cases with male breast cancer, identifying a novel pathogenic variant of ATR (p.Leu1808*). ATR has already been suspected as being a predisposing gene to breast cancer in women. We next identified 3 additional ATR variants in a cohort of both male and female with early onset and familial breast cancers (c.7762-2A>C; c.2078+1G>A; c.1A>G). Further molecular and cellular investigations showed impacts on transcripts for variants affecting splicing sites and reduction of ATR expression and phosphorylation of the ATR substrate CHEK1. This work further demonstrates the interest of an extended genetic analysis such as exome sequencing to identify very rare variants that can play a role in cancer predisposition in extreme phenotype cancer cases unexplained by classical cancer gene panels testing.
Collapse
Affiliation(s)
- Martin Chevarin
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Unité Fonctionnelle Innovation diagnostique dans les maladies rares, laboratoire de génétique chromosomique et moléculaire, Plateau Technique de Biologie, CHU Dijon Bourgogne, Dijon, France
| | - Diana Alcantara
- Human DNA Damage Response Disorders Group, University of Sussex, Genome Damage and Stability Centre, Brighton, United Kingdom
| | - Juliette Albuisson
- Service d’Oncogénétique, Centre Georges François Leclerc, Dijon, France
- Département de biologie et pathologie des tumeurs, Centre Georges François Leclerc, Dijon, France
| | | | - Céline Populaire
- Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France
| | - Zohair Selmani
- Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France
| | - Amandine Baurand
- Service d’Oncogénétique, Centre Georges François Leclerc, Dijon, France
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
| | - Caroline Sawka
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
| | - Geoffrey Bertolone
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
| | - Patrick Callier
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Unité Fonctionnelle Innovation diagnostique dans les maladies rares, laboratoire de génétique chromosomique et moléculaire, Plateau Technique de Biologie, CHU Dijon Bourgogne, Dijon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| | - Yannis Duffourd
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| | - Philippe Jonveaux
- Laboratoire de Génétique Médicale, INSERM U954, Hôpitaux de Brabois, Vandoeuvre les Nancy, France
| | - Yves-Jean Bignon
- Laboratoire d’Oncologie Moléculaire, Centre Jean Perrin, Clermont-Ferrand, France
| | | | - François Cornelis
- Université Bordeaux, IMB, UMR 5251, Talence, France
- Service d’imagerie diagnostique et interventionnelle de l’adulte, Hôpital Pellegrin, CHU de Bordeaux, France
| | | | | | - Jean-Baptiste Rivière
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| | - Paul Kuentz
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| | - Christel Thauvin
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
| | - Romain Boidot
- Département de biologie et pathologie des tumeurs, Centre Georges François Leclerc, Dijon, France
| | - François Ghiringhelli
- Département d’oncologie médicale, INSERM LNC U1231, Centre Georges François Leclerc, Dijon, France
| | - Marc O'Driscoll
- Human DNA Damage Response Disorders Group, University of Sussex, Genome Damage and Stability Centre, Brighton, United Kingdom
| | - Laurence Faivre
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Service d’Oncogénétique, Centre Georges François Leclerc, Dijon, France
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| | - Sophie Nambot
- Inserm UMR 1231 GAD Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
- Service d’Oncogénétique, Centre Georges François Leclerc, Dijon, France
- Centre de Génétique et Centre de Référence Maladies Rares Anomalies du Développement de l’Interrégion Est, Hôpital d’Enfants, CHU Dijon Bourgogne, Dijon, France
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France
| |
Collapse
|
7
|
Catapano F, El Hachmi M, Ketterer-Heng N, Renieri A, Mari F, Morris M, Cordier C. The role of the Genetic Counsellor in the multidisciplinary team: the perception of geneticists in Europe. Eur J Hum Genet 2022; 30:1432-1438. [PMID: 36198805 PMCID: PMC9712381 DOI: 10.1038/s41431-022-01189-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 08/24/2022] [Accepted: 09/06/2022] [Indexed: 11/09/2022] Open
Abstract
Genetics has begun to be considered a key medical discipline which can have an impact on everyday clinical practice. Therefore, it is necessary to understand what the most effective way is of caring for people affected by or at risk of genetic disorders. In this context, the team dealing with such patients has evolved with the emergence of the Genetic Counsellor figure. The profession of Genetic Counsellor appeared in Europe in 1980, but it is still a much-debated profession and not yet recognized in all European countries. The aim of this research is to investigate both how a team should be composed in the care of patients affected by or at risk of genetic disorders and what the role of the Genetic Counsellor should be-the field of action and the competences. The research has been carried out at the European level, submitting an online questionnaire to geneticists who, having the ultimate responsibility for the diagnosis and being in the field for the longest time, expressing their opinion, can identify strengths and potential areas for improvement in genetic care. 200 responses were collected from all over Europe. This led to awareness of the importance of the role of the counsellor within the medical genetics multidisciplinary team, and, above all, what the counsellor's skills and qualifications should be-for geneticists. Although this new profession has difficulties in being recognized in some countries, it seems clear that these highly competent professionals are essential for in-patient care and in the multidisciplinary team.
Collapse
Affiliation(s)
- Francesca Catapano
- Medical Genetics, University of Siena, Siena, Italy.
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland.
| | - Mohamed El Hachmi
- Medical Genetics, University of Siena, Siena, Italy
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| | | | - Alessandra Renieri
- Medical Genetics, University of Siena, Siena, Italy
- Medical Genetics, Azienda Ospedaliera Universitaria Senese, Siena, Italy
| | - Francesca Mari
- Medical Genetics, University of Siena, Siena, Italy
- Medical Genetics, Azienda Ospedaliera Universitaria Senese, Siena, Italy
| | - Michael Morris
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| | - Christophe Cordier
- Medical Genetics, University of Siena, Siena, Italy
- Department of Genetics, SYNLAB Suisse SA, Lausanne, Switzerland
| |
Collapse
|
8
|
Tobias ES, Avram E, Calapod P, Cordier C, den Dunnen JT, Ding C, Dolzan V, Houge SD, Lynch SA, O'Byrne J, Patsalis P, Prokopenko I, Soares CA, Tobias AP, Newman WG. The Role of the European Society of Human Genetics in Delivering Genomic Education. Front Genet 2021; 12:693952. [PMID: 34539735 PMCID: PMC8446627 DOI: 10.3389/fgene.2021.693952] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2021] [Accepted: 07/22/2021] [Indexed: 11/13/2022] Open
Abstract
The European Society of Human Genetics (ESHG) was founded in 1967 as a professional organisation for members working in genetics in clinical practice, research and education. The Society seeks the integration of scientific research and its implementation into clinical practice and the education of specialists and the public in all areas of medical and human genetics. The Society works to do this through many approaches, including educational sessions at the annual conference; training courses in general and specialist areas of genetics; an online resource of educational materials (EuroGEMS); and a mentorship scheme. The ESHG Education Committee is implementing new approaches to expand the reach of its educational activities and portfolio. With changes in technology, appreciation of the utility of genomics in healthcare and the public's and patients' increased awareness of the role of genomics, this review will summarise how the ESHG is adapting to deliver innovative educational activity.
Collapse
Affiliation(s)
- Edward S Tobias
- Academic Unit of Medical Genetics and Clinical Pathology, Laboratory Medicine Building, Queen Elizabeth University Hospital, University of Glasgow, Glasgow, United Kingdom.,School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.,Clinical Genetics, West of Scotland Centre for Genomic Medicine, Laboratory Medicine Bldg., NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, United Kingdom
| | - Elena Avram
- MedLife, Bucharest, Romania.,Department of Medical Genetics, Faculty of Medicine, Lucian Blaga University of Sibiu, Sibiu, Romania
| | | | | | - Johan T den Dunnen
- Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands.,Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
| | - Can Ding
- Institute of Human Genetics, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany
| | - Vita Dolzan
- Pharmacogenetics Laboratory, Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, University of Ljubljana, Ljubljana, Slovenia
| | - Sofia Douzgou Houge
- Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.,Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.,Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, United Kingdom
| | - Sally Ann Lynch
- Clinical Genetics, Children's Health Ireland at Crumlin and Temple Street, Dublin, Ireland
| | - James O'Byrne
- National Centre for Inherited Metabolic Diseases, Mater Misericordiae University Hospital, Dublin, Ireland
| | - Philippos Patsalis
- NIPD Genetics Limited, Nicosia, Cyprus.,Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus
| | - Inga Prokopenko
- Department of Clinical and Experimental Medicine, University of Surrey, Guildford, United Kingdom.,Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
| | - Celia A Soares
- Centro de Genética Médica Jacinto Magalhães, Centro Hospitalar Universitário do Porto, Porto, Portugal.,Unit for Multidisciplinary Research in Biomedicine, Instituto de Ciências Biomédicas Abel Salazar/Universidade do Porto, Porto, Portugal
| | - Adam P Tobias
- Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom
| | - William G Newman
- Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.,Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.,Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, United Kingdom
| |
Collapse
|
9
|
Stefansdottir V, Thorolfsdottir E, Hognason HB, Patch C, van El C, Hentze S, Cordier C, Mendes Á, Jonsson JJ. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland. Eur J Hum Genet 2020; 28:1656-1661. [PMID: 32523053 PMCID: PMC7784695 DOI: 10.1038/s41431-020-0665-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Revised: 05/18/2020] [Accepted: 05/26/2020] [Indexed: 11/09/2022] Open
Abstract
There is an increased pressure to return results from research studies. In Iceland, deCODE Genetics has emphasised the importance of returning results to research participants, particularly the founder pathogenic BRCA2 variant; NM_000059.3:c.771_775del. To do so, they opened the website www.arfgerd.is . Individuals who received positive results via the website were offered genetic counselling (GC) at Landspitali in Reykjavik. At the end of May 2019, over 46.000 (19% of adults of Icelandic origin) had registered at the website and 352 (0.77%) received text message informing them about their positive results. Of those, 195 (55%) contacted the GC unit. Additionally, 129 relatives asked for GC and confirmatory testing, a total of 324 individuals. Various information such as gender and age, prior knowledge of the variant and perceived emotional impact, was collected. Of the BRCA2 positive individuals from the website, 74 (38%) had prior knowledge of the pathogenic variant (PV) in the family. The majority initially stated worries, anxiety or other negative emotion but later in the process many communicated gratitude for the knowledge gained. Males represented 41% of counsellees as opposed to less than 30% in the regular hereditary breast and ovarian (HBOC) clinic. It appears that counselling in clinical settings was more reassuring for worried counsellees. In this article, we describe one-year experience of the GC service to those who received positive results via the website. This experience offers a unique opportunity to study the public response of a successful method of the return of genetic results from research.
Collapse
Affiliation(s)
- Vigdis Stefansdottir
- Department of Genetics and Molecular Medicine, Iceland, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland.
| | - Eirny Thorolfsdottir
- Department of Genetics and Molecular Medicine, Iceland, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland
| | - Hakon B Hognason
- Department of Genetics and Molecular Medicine, Iceland, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland
| | - Christine Patch
- Florence Nightingale Faculty, Nursing and Midwifery & Palliative Care, King's College London, London, UK
| | - Carla van El
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics and Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
| | | | - Christophe Cordier
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205, Genève, Switzerland
- Département de génétique, SYNLAB, Chemin d'Entre-Bois 21, 1018, Lausanne, Switzerland
| | - Álvaro Mendes
- UnIGENe and CGPP - Centre for Predictive and Preventive Genetics, IBMC - Institute for Molecular and Cell Biology, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
| | - Jon J Jonsson
- Department of Genetics and Molecular Medicine, Iceland, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Iceland, Reykjavik 101, Reykjavik, Iceland
| |
Collapse
|
10
|
Coulon P, Cordier C, Saint-Léger P, Lambiotte F, Loridant S, Mazars E. Invasive pulmonary aspergillosis in an ICU patient with Legionnaires' disease: A diagnostic challenge. J Mycol Med 2020; 30:100985. [PMID: 32418638 DOI: 10.1016/j.mycmed.2020.100985] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Accepted: 04/20/2020] [Indexed: 02/06/2023]
Abstract
Aspergillus fumigatus can cause a wide range of diseases, from hypersensitivity to invasive infection. Invasive disease usually occurs in severely immunocompromised patients with deep and prolonged neutropenia. It is a less well-recognized complication in critically ill patients without traditional risk factors. We describe a case of early invasive pulmonary aspergillosis (IPA) secondary to Legionella pneumophila serogroup 1 pneumonia in a patient on an intensive care unit (ICU). In addition to commonly accepted risk factors for IPA in ICU patients, we hypothesis that L. pneumophilia pneumonia could enhance this type of infection. We also reviewed all published cases of coinfection with L. pneumophila and A. fumigatus to assess whether Legionnaires' disease could be a risk factor for IPA.
Collapse
Affiliation(s)
- P Coulon
- Inserm U995-LIRIC (Lille Inflammation Research International Centre), laboratoire de parasitologie mycologie, université Lille, CHU Lille, 1, place Verdun, 59000 Lille, France
| | - C Cordier
- Laboratoire de microbiologie, pôle de biologie-hygiène, centre hospitalier de Valenciennes, avenue Désandrouin, 59322 Valenciennes, France
| | - P Saint-Léger
- Service de réanimation polyvalente, centre hospitalier de Valenciennes, avenue Désandrouin, 59322 Valenciennes, France
| | - F Lambiotte
- Service de réanimation polyvalente, centre hospitalier de Valenciennes, avenue Désandrouin, 59322 Valenciennes, France
| | - S Loridant
- Inserm U995-LIRIC (Lille Inflammation Research International Centre), laboratoire de parasitologie mycologie, université Lille, CHU Lille, 1, place Verdun, 59000 Lille, France
| | - E Mazars
- Laboratoire de microbiologie, pôle de biologie-hygiène, centre hospitalier de Valenciennes, avenue Désandrouin, 59322 Valenciennes, France.
| |
Collapse
|
11
|
Cina V, Met-Domestici M, Davoine E, Ayme A, Brockmann C, Cordier C, Murphy A. [Not Available]. Rev Med Suisse 2019; 15:1291-1293. [PMID: 31268259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- Viviane Cina
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Service de médecine génétique, Département de médecine, CHUV, 1011 Lausanne
| | - Marie Met-Domestici
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Service de médecine génétique, Département de médecine, CHUV, 1011 Lausanne
| | - Emeline Davoine
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Service de médecine génétique, Département de médecine, CHUV, 1011 Lausanne
| | - Aurélie Ayme
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Unité d'oncogénétique et de prévention des cancers, HUG, 1211 Genève 14
| | - Céline Brockmann
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Bioscope, Université de Genève, 1211 Genève 4
| | - Christophe Cordier
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Département de génétique, SYNLAB, Chemin d'Entre-Bois 21, 1018 Lausanne
| | - Anne Murphy
- Association suisse des conseillers en génétique, c/o Anne Murphy, 26 rue de la Colline, 1205 Genève
- Service de médecine génétique, HUG, 1211 Genève 14
| |
Collapse
|
12
|
Abacan M, Alsubaie L, Barlow-Stewart K, Caanen B, Cordier C, Courtney E, Davoine E, Edwards J, Elackatt NJ, Gardiner K, Guan Y, Huang LH, Malmgren CI, Kejriwal S, Kim HJ, Lambert D, Lantigua-Cruz PA, Lee JMH, Lodahl M, Lunde Å, Macaulay S, Macciocca I, Margarit S, Middleton A, Moldovan R, Ngeow J, Obregon-Tito AJ, Ormond KE, Paneque M, Powell K, Sanghavi K, Scotcher D, Scott J, Juhé CS, Shkedi-Rafid S, Wessels TM, Yoon SY, Wicklund C. The Global State of the Genetic Counseling Profession. Eur J Hum Genet 2019; 27:183-197. [PMID: 30291341 PMCID: PMC6336871 DOI: 10.1038/s41431-018-0252-x] [Citation(s) in RCA: 160] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2018] [Revised: 07/26/2018] [Accepted: 08/09/2018] [Indexed: 11/30/2022] Open
Abstract
The profession of genetic counseling (also called genetic counselling in many countries) began nearly 50 years ago in the United States, and has grown internationally in the past 30 years. While there have been many papers describing the profession of genetic counseling in individual countries or regions, data remains incomplete and has been published in diverse journals with limited access. As a result of the 2016 Transnational Alliance of Genetic Counseling (TAGC) conference in Barcelona, Spain, and the 2017 World Congress of Genetic Counselling in the UK, we endeavor to describe as fully as possible the global state of genetic counseling as a profession. We estimate that in 2018 there are nearly 7000 genetic counselors with the profession established or developing in no less than 28 countries.
Collapse
Affiliation(s)
- MaryAnn Abacan
- Institute of Human Genetics, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
| | - Lamia Alsubaie
- King Abdullah Specialized Children's Hospital (KASCH), King Abdulaziz Medical City, Riyadh, Saudi Arabia
| | - Kristine Barlow-Stewart
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
| | - Beppy Caanen
- Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
| | | | - Eliza Courtney
- Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
| | | | - Janice Edwards
- Transnational Alliance for Genetic Counseling, University of South Carolina Genetic Counseling Program, University of South Carolina, Columbia, SC, USA
| | - Niby J Elackatt
- Organization for Rare Diseases India, Cloudnine Hospitals, Bangalore, India
| | | | - Yue Guan
- Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - Lian-Hua Huang
- School of Nursing, China Medical University, Taichung, Taiwan
- School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan
| | - Charlotta Ingvoldstad Malmgren
- Center for Fetal Medicine and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
- Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden
- Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
| | - Sahil Kejriwal
- Institute for Public Health Genetics, University of Washington, Seattle, USA
| | - Hyon J Kim
- Ajou Univ. Medical School and Konyang Univ. Graduate school, Yeongtong-gu, Suwon, South Korea
| | | | | | | | - Marianne Lodahl
- Department of Clinical Genetics Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | - Åshild Lunde
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
| | - Shelley Macaulay
- Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand & The National Health Laboratory Service, Johannesburg, South Africa
| | - Ivan Macciocca
- Victorian Clinical Genetics Services, Melbourne, Australia
| | - Sonia Margarit
- Clínica Alemana Universidad del Desarrollo, Facultad de Medicina, Centro de Genética y Genómica, Santiago, Chile
| | - Anna Middleton
- Society and Ethics Research, Connecting Science, Wellcome Genome Campus, Cambridge, UK
- Faculty of Education, University of Cambridge, Cambridge, UK
| | - Ramona Moldovan
- Department of Psychology, Babeș-Bolyai University, Cluj-Napoca, Romania
| | - Joanne Ngeow
- Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
| | | | - Kelly E Ormond
- Department of Genetics and Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, USA.
- Stanford University School of Medicine, 300 Pasteur Drive, MC 5208, Stanford, CA, USA.
| | - Milena Paneque
- i3S - Instituto de Investigação e Inovação em Saúde, CGPP - Centre for Predictive and Preventive Genetics and IBMC - Institute for Molecular and Cell Biology, Universidade do Porto, Porto, Portugal
| | | | - Kunal Sanghavi
- The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA
| | - Diana Scotcher
- Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Saint Mary's Hospital, Manchester, UK
| | - Jenna Scott
- University of British Columbia, Vancouver, BC, Canada
| | - Clara Serra Juhé
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Institut Hospital del Mar d'Investigacions Mèdiques, Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain
| | | | - Tina-Marié Wessels
- Division Human Genetics, University of Cape Town, Cape Town, South Africa
| | - Sook-Yee Yoon
- Cancer Research, Subang Jaya, Malaysia
- University Malaya Medical Centre, Kuala Lumpur, Malaysia
- National University of Malaysia, Kuala Lumpur, Malaysia
| | | |
Collapse
|
13
|
Sirchia F, Carrieri D, Dheensa S, Benjamin C, Kayserili H, Cordier C, van El CG, Turnpenny PD, Melegh B, Mendes Á, Halbersma-Konings TF, van Langen IM, Lucassen AM, Clarke AJ, Forzano F, Kelly SE. Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe. Eur J Hum Genet 2018; 26:946-954. [PMID: 29681620 PMCID: PMC6018700 DOI: 10.1038/s41431-018-0131-5] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 02/16/2018] [Accepted: 02/23/2018] [Indexed: 11/09/2022] Open
Abstract
Advances in genomic medicine are improving diagnosis and treatment of some health conditions, and the question of whether former patients should be recontacted is therefore timely. The issue of recontacting is becoming more important with increased integration of genomics in 'mainstream' medicine. Empirical evidence is needed to advance the discussion over whether and how recontacting should be implemented. We administered a web-based survey to genetic services in European countries to collect information about existing infrastructures and practices relevant to recontacting patients. The majority of the centres stated they had recontacted patients to update them about new significant information; however, there were no standardised practices or systems in place. There was also a multiplicity of understandings of the term 'recontacting', which respondents conflated with routine follow-up programmes, or even with post-test counselling. Participants thought that recontacting systems should be implemented to provide the best service to the patients and families. Nevertheless, many barriers to implementation were mentioned. These included: lack of resources and infrastructure, concerns about potential negative psychological consequences of recontacting, unclear operational definitions of recontacting, policies that prevent healthcare professionals from recontacting, and difficulties in locating patients after their last contact. These barriers are also intensified by the highly variable development (and establishment) of the specialties of medical genetics and genetic counselling across different European countries. Future recommendations about recontacting need to consider these barriers. It is also important to reach an 'operational definition' that can be useful in different countries.
Collapse
Affiliation(s)
- Fabio Sirchia
- Department of Medical Sciences and Medical Genetics Unit, Città della Salute e della Scienza University Hospital, University of Torino, Torino, Italy
| | | | - Sandi Dheensa
- Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK
| | - Caroline Benjamin
- School of Community Health & Midwifery, University of Central Lancashire (UCLan), Preston, England, UK
- Liverpool Women's NHS Hospital Trust, England, UK
| | - Hülya Kayserili
- Department of Medical Genetics, Koç University School of Medicine İstanbul, İstanbul, Turkey
| | | | - Carla G van El
- Department of Clinical Genetics, Section Community Genetics and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands
| | - Peter D Turnpenny
- Clinical Genetics, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK
| | - Bela Melegh
- Department of Medical Genetics, and Szentagothai Research Ctr, University of Pécs Medical School, Pécs, Hungary
| | - Álvaro Mendes
- UnIGENe and CGPP-Centre for Predictive and Preventive Genetics, IBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
| | - Tanya F Halbersma-Konings
- Deparment of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| | - Irene M van Langen
- Deparment of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| | - Anneke M Lucassen
- Clinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK
- Wessex Clinical Genetics Service, University Hospitals Southampton NHS Foundation Trust, Southampton, UK
| | | | - Francesca Forzano
- Clinical Genetics Department, Guy's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK
| | | |
Collapse
|
14
|
Pestoff R, Moldovan R, Cordier C, Serra-Juhé C, Paneque M, Ingvoldstad CM. How practical experiences, educational routes and multidisciplinary teams influence genetic counselors' clinical practice in Europe. Clin Genet 2018; 93:891-898. [PMID: 29251775 DOI: 10.1111/cge.13197] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Revised: 12/08/2017] [Accepted: 12/13/2017] [Indexed: 11/29/2022]
Abstract
The main objective of our study was to explore whether, and to what extent, genetic counselors' characteristics impact on their tasks in practice. Specifically, we explored the complementariness between genetic counselors and medical geneticists and therefore looked at the most relevant tasks of genetic counselors, according to genetic counselors themselves and according to the medical geneticists they work with. A total of 104 genetic counselors and 29 medical geneticists from 15 countries completed a purposefully designed questionnaire. Results showed that most genetic counselors in Europe perform similar tasks, irrespective of their backgrounds. When looking at the factors influencing genetic counselors' roles data showed that the type of tasks performed by genetic counselors is associated with the years of experience in the field, not with their background or education. Of particular interest was the consensus between genetic counselors and medical geneticists regarding the genetic counselor's role. Not surprisingly, tasks with more psychosocial implications were seen as genetic counselors' eligibility while tasks with more medical implications were seen as medical geneticists' attribution. Our study shows that most genetic counselors work in tune with international recommendations and seem to be supportive of multidisciplinary teams. Corroborating our data with previous research, we discuss potential implications for practice and training in genetic counseling.
Collapse
Affiliation(s)
- R Pestoff
- Department of Clinical Genetics, Linköping University Hospital, Linköping, Sweden.,Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
| | - R Moldovan
- Department of Psychology, Babeş-Bolyai University, Cluj-Napoca, Romania
| | - C Cordier
- Department of Genetics, Synlab Genetics, Lausanne, Switzerland
| | - C Serra-Juhé
- Genetics Unit, Universitat Pompeu Fabra - Hospital del Mar Research Institute (IMIM), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
| | - M Paneque
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.,Centre for Predictive and Preventive Genetics CGPP- IBMC - Institute for Molecular and Cell Biology Universidade do Porto, Porto, Portugal
| | - C M Ingvoldstad
- Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden.,Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.,Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
| |
Collapse
|
15
|
Paneque M, Serra-Juhé C, Pestoff R, Cordier C, Silva J, Moldovan R, Ingvoldstad C. Complementarity between medical geneticists and genetic counsellors: its added value in genetic services in Europe. Eur J Hum Genet 2017; 25:918-923. [PMID: 28513616 DOI: 10.1038/ejhg.2017.76] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 02/21/2017] [Accepted: 04/05/2017] [Indexed: 11/09/2022] Open
Abstract
Clinical genetic services have progressed significantly the last few decades. This has led to the need for non-medical health-care professionals working as genetic counsellors in Europe and worldwide. However, there is no unified approach to genetic counsellors' role in health-care services in Europe, as in most countries the profession is still emerging and the educational backgrounds diverge noticeably, within and between countries. This qualitative study aims to describe the potential added value of genetic counsellors in clinical genetics teams and to explore their tasks and responsibilities in different European countries. A total of 143 participants providing genetic counselling in Europe at the time of the survey responded. The results show differences in activities of genetic counsellors, although there is a wide range of roles, which are similar. The ability to establish a quality relationship with consultands was frequently mentioned as one of the strengths of genetic counsellors, as well as a patient-centred approach. It is believed that genetic counsellors add a more holistic approach of psychosocial and familial dimensions of genetic concerns to the multidisciplinary teams. This study provides examples of successful integration of genetic counsellors in teams, as complementariness with medical geneticist became clear in several cases. Although the added value of genetic counsellors was manifested, professional recognition of genetic counsellors across Europe is still needed in order to support the quality of patients care and safety of practice.
Collapse
Affiliation(s)
- Milena Paneque
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.,IBMC - Institute for Molecular and Cell Biology, Universidade do Porto, Porto, Portugal.,Centre for Predictive and Preventive Genetics (CGPP), Universidade do Porto, Porto, Portugal
| | - Clara Serra-Juhé
- Genetics Unit, Universitat Pompeu Fabra - Hospital del Mar Research Institute (IMIM), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
| | - Rebecka Pestoff
- Department of Clinical Genetics, Linköping University Hospital, Linköping, Sweden.,Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
| | | | - João Silva
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.,IBMC - Institute for Molecular and Cell Biology, Universidade do Porto, Porto, Portugal.,Centre for Predictive and Preventive Genetics (CGPP), Universidade do Porto, Porto, Portugal
| | - Ramona Moldovan
- Department of Psychology, Babeş-Bolyai University, Cluj-Napoca, Romania
| | - Charlotta Ingvoldstad
- Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden.,Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.,Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
| |
Collapse
|
16
|
Allou N, Coolen-Allou N, Delmas B, Cordier C, Allyn J. [Severe pulmonary embolism revealed by status epilepticus]. Rev Pneumol Clin 2016; 72:377-379. [PMID: 27810245 DOI: 10.1016/j.pneumo.2016.10.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Accepted: 10/01/2016] [Indexed: 06/06/2023]
Abstract
INTRODUCTION High-risk pulmonary embolism (PE) is associated with high mortality rate (>50%). In some cases, diagnosis of PE remains a challenge with atypical presentations like in this case report with a PE revealed by status epilepticus. CASE REPORT We report the case of a 40-year-old man without prior disease, hospitalized in ICU for status epilepticus. All paraclinical examinations at admission did not show any significant abnormalities (laboratory tests, cardiologic and neurological investigations). On day 1, he presented a sudden circulatory collapse and echocardiography showed right intra-auricular thrombus. He was treated by thrombolysis and arteriovenous extracorporeal membrane oxygenation. After stabilization, computed tomography showed severe bilateral PE. He developed multi-organ failure and died 4days after admission. CONCLUSIONS Pulmonary embolism revealed by status epilepticus has rarely been reported and is associated with poor prognosis. Physicians should be aware and think of the possibility of PE in patients with status epilepticus without any history or risk factors of seizure and normal neurological investigations.
Collapse
Affiliation(s)
- N Allou
- Réanimation polyvalente, CHU Félix-Guyon, allée des Topazes, 97400 Saint-Denis, France.
| | - N Coolen-Allou
- Pneumologie, CHU Félix-Guyon, allée des Topazes, 97400 Saint-Denis, France.
| | - B Delmas
- Réanimation polyvalente, CHU Félix-Guyon, allée des Topazes, 97400 Saint-Denis, France.
| | - C Cordier
- Réanimation polyvalente, CHU Félix-Guyon, allée des Topazes, 97400 Saint-Denis, France.
| | - J Allyn
- Réanimation polyvalente, CHU Félix-Guyon, allée des Topazes, 97400 Saint-Denis, France.
| |
Collapse
|
17
|
Gillmann F, Cordier C, Taris N, Mathelin C, Maugard CM. Mise en place des modalités de réunions de concertation pluridisciplinaire pour la prise en charge des patientes prédisposées héréditairement au cancer du sein. Une étude française. Bull Cancer 2016; 103:571-83. [DOI: 10.1016/j.bulcan.2016.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Revised: 02/29/2016] [Accepted: 03/22/2016] [Indexed: 11/24/2022]
|
18
|
Martel-Billard C, Cordier C, Tomasetto C, Jégu J, Mathelin C. Cancer du sein et trisomie 21 : une anomalie génétique qui protège contre le cancer du sein ? ACTA ACUST UNITED AC 2016; 44:211-7. [DOI: 10.1016/j.gyobfe.2016.02.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2015] [Accepted: 02/29/2016] [Indexed: 01/22/2023]
|
19
|
Paneque M, Moldovan R, Cordier C, Serra-Juhé C, Feroce I, Lambert D, Bjørnevoll I, Skirton H. Development of a registration system for genetic counsellors and nurses in health-care services in Europe. Eur J Hum Genet 2015; 24:312-4. [PMID: 26531169 PMCID: PMC4755385 DOI: 10.1038/ejhg.2015.234] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2015] [Revised: 09/25/2015] [Accepted: 10/01/2015] [Indexed: 11/09/2022] Open
Affiliation(s)
- Milena Paneque
- Centre for Predictive and Preventive Genetics (CGPP) and UnIGENe, IBMC, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.,Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria
| | - Ramona Moldovan
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,Department of Psychology, Babeş-Bolyai University, Cluj-Napoca, Romania
| | - Christophe Cordier
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,Department of Oncology and Haematology, CHRU Strasbourg, Strasbourg, France
| | - Clara Serra-Juhé
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,Genetics Unit, Universitat Pompeu Fabra-Hospital del Mar Research Institute (IMIM), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
| | - Irene Feroce
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
| | - Debby Lambert
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,National Rare Disease Office, Mater Misericordiae University Hospital, Dublin, Ireland
| | - Inga Bjørnevoll
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
| | - Heather Skirton
- Genetic Nurse and Counsellor Professional Branch Board, European Board of Medical Genetics, Vienna, Austria.,School of Nursing and Midwifery, Plymouth University, Plymouth, UK
| |
Collapse
|
20
|
Ingvoldstad C, Seven M, Taris N, Cordier C, Paneque M, Skirton H. Components of genetic counsellor education: A systematic review of the peer-reviewed literature. J Community Genet 2015; 7:107-18. [PMID: 26452349 DOI: 10.1007/s12687-015-0255-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2015] [Accepted: 09/28/2015] [Indexed: 02/04/2023] Open
Abstract
The need for appropriately trained genetic counsellors to support genetic healthcare is now acknowledged. However, while programmes for education of genetic counsellors exist in a number of countries, these do not conform to any specific international standards. As genetic techniques, educational standards and professional standards have been evolved, and with increasing mobility of genetic counsellors, it is of great importance to have some comparison of education and training between different countries. This systematic review was conducted to determine the components of educational programmes for genetic counsellors worldwide that have been published in peer-reviewed literature. Databases were searched for studies published in English from 2000 to 2014 related to the topic. We identified 406 potential papers, of these, 11 studies met the inclusion criteria. The findings indicate that, in most cases, the theoretical components of genetic counsellor programmes conform to the recommendations and requirements of relevant professional bodies. However, clinical preparation of genetic counsellors in real-life professional practice settings seems to be less well addressed as this is essential to ensure genetic counsellors are able to provide safe patient care after graduation. Further work to gain agreement internationally on genetic counsellor education is needed.
Collapse
Affiliation(s)
- C Ingvoldstad
- Karolinska Institute, CLINTECH, Obstetrics and Gynaecology, Stockholm, Sweden.
| | - M Seven
- Koç University School of Nursing, İstanbul, Turkey
| | - N Taris
- Department of Oncogenetics, Centre Paul Strauss, Strasbourg, France
| | - C Cordier
- Department of Oncogenetics, Hospital of Strasbourg, Strasbourg, France
| | - M Paneque
- Center for Predictive and Preventive Genetics, Institute for Molecular and Cell Biology, Porto, Portugal
| | - H Skirton
- Faculty of Health and Human Sciences, Plymouth University, Plymouth, UK
| |
Collapse
|
21
|
Meurice T, Tricot O, Lemesle G, Deneve M, Lejeune P, Biausque F, Cordier C, Savoye C, Hennebert O, Taghipour K, Sivery B, Pruvost P, Alaoui M, Carpentier L, Segrestin B, Lamblin N, Bauters C. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease. Arch Cardiovasc Dis 2015; 108:340-6. [PMID: 25858539 DOI: 10.1016/j.acvd.2015.01.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2014] [Revised: 12/22/2014] [Accepted: 01/12/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND In patients with coronary artery disease (CAD), non-optimal use of evidence-based medications is associated with an increased risk of adverse outcome. AIMS To assess the prevalence and correlates of non-optimal secondary medical prevention in patients with stable CAD. METHODS We included 4184 consecutive outpatients with stable CAD. Treatment at inclusion was classified as optimal/non-optimal regarding the four major classes of secondary prevention drugs: antithrombotics; statins; angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs); and beta-blockers. For each treatment, the prescription was considered non-optimal if the drug was missing despite a class IA indication according to international guidelines. To assess the information globally, non-optimal secondary prevention was defined as at least one major treatment missing. RESULTS The proportions of patients with non-optimal treatment were 0.7%, 7.8%, 12.9% and 10.3% for antithrombotics, statins, ACE inhibitors/ARBs and beta-blockers, respectively. Non-optimal secondary medical prevention was observed in 16.8% of cases. By multivariable analysis, the correlates of non-optimal secondary medical prevention were long time interval since last coronary event (P<0.0001), older age (P<0.0001), diabetes mellitus (P<0.0001), hypertension (P<0.0001), no history of myocardial infarction (P=0.001), no history of coronary revascularization (P=0.013) and low glomerular filtration rate (P=0.042). CONCLUSIONS Although most patients with stable CAD are receiving evidence-based medications according to guidelines, there remain subgroups at higher risk of non-optimal treatment. In particular, it might be feasible to improve prevention by focusing on patients in whom a long time has elapsed since the last coronary event.
Collapse
Affiliation(s)
| | | | - Gilles Lemesle
- Centre Hospitalier Régional et Universitaire de Lille, Lille, France; Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France; Faculté de Médecine de Lille, Lille, France
| | - Michel Deneve
- Centre Hospitalier Régional et Universitaire de Lille, Lille, France
| | | | | | | | | | | | | | - Bruno Sivery
- Centre Hospitalier de Wattrelos, Wattrelos, France
| | | | - Moulay Alaoui
- Centre Hospitalier de Boulogne-sur-mer, Boulogne-sur-mer, France
| | | | | | - Nicolas Lamblin
- Centre Hospitalier Régional et Universitaire de Lille, Lille, France; Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France; Faculté de Médecine de Lille, Lille, France
| | - Christophe Bauters
- Centre Hospitalier Régional et Universitaire de Lille, Lille, France; Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France; Faculté de Médecine de Lille, Lille, France.
| |
Collapse
|
22
|
Cordier C, Taris N, De Pauw A, Sobol H, Philip N, Voelckel MA. French professionals in genetic counselor careers. J Genet Couns 2013; 22:844-8. [PMID: 23689926 DOI: 10.1007/s10897-013-9599-x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2012] [Accepted: 04/17/2013] [Indexed: 10/26/2022]
Abstract
The profession of genetic counseling in France was recognized in 2004, based on the recommendations of a mandate commissioned by the Health Minister to explore the medical demographics of France. The report predicted a shortage of health professionals in the field of genetics, particularly in light of the rapid development of molecular testing. Development of the profession was supported by a legal framework, and today 107 genetic counselors have graduated from the specific educational program which awards the Professional Master's Degree of Human Pathology, entitled Master in Genetic Counseling and Predictive Medicine. Here we will trace the development of the profession in France and review the demographic characteristics of the students and genetic counselors practicing the profession today.
Collapse
Affiliation(s)
- C Cordier
- Department of Oncology and Haematology, Consultation of Oncogenetics, Hospital of Strasbourg, 1 rue porte de l'Hôpital, 67000, Strasbourg, France,
| | | | | | | | | | | |
Collapse
|
23
|
Skirton H, Cordier C, Lambert D, Hosterey Ugander U, Voelckel MA, O'Connor A. A study of the practice of individual genetic counsellors and genetic nurses in Europe. J Community Genet 2013; 4:69-75. [PMID: 23055100 PMCID: PMC3537977 DOI: 10.1007/s12687-012-0119-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2012] [Accepted: 09/18/2012] [Indexed: 10/27/2022] Open
Abstract
Advances in genetics have meant that the genetic services are now accessed by increasing numbers of patients. One way of dealing with the pressure on services without jeopardising patient care is the inclusion of nonmedical genetic counsellors and genetic nurses in the genetic services team. However, a cohesive approach to the profession has been lacking in Europe, and an educational programme and registration system for European practitioners is required. The aim of this study was to ascertain the type of work undertaken by genetic nurses and counsellors in Europe and the context in which they practised. We used a cross-sectional survey design to collect data from 213 practitioners, either genetic nurses or genetic counsellors, from 18 European countries. Respondents completed the survey online, and data were analysed using descriptive statistics and cross-tabulations. The majority were involved in undertaking the initial contact with the patient (89.9 %) and explaining the genetic test to the patient (91.5 %), while 74 % ordered tests and 91.4 % obtained informed consent for such tests. Psychological support before and after genetic testing was provided by 80.2 % of respondents, and 82.1 % reported regularly managing cases autonomously. While the genetic counselling profession is barely established in some countries, counsellors are able to contribute substantially to patient care as part of the multi-disciplinary team. Further efforts to establish the profession at the European level through a registration process will enhance the confidence in this new group of allied health professionals.
Collapse
Affiliation(s)
- Heather Skirton
- Faculty of Health, Education and Society, Plymouth University, Wellington Road, Taunton, TA1 5YD, UK,
| | | | | | | | | | | |
Collapse
|
24
|
Mimassi L, Cordier C, Guyard-Duhayon C, Mann BE, Amouri H. Chiral Supramolecular Triangular Hosts: Anion Metathesis, Solution Behavior, and High Stability of the Metal Configuration. Organometallics 2007. [DOI: 10.1021/om060756s] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- L. Mimassi
- Laboratoire de Chimie Inorganique et Matériaux Moléculaires UMR CNRS 7071, Université Pierre et Marie Curie, 4 place Jussieu, case 42, 75252 Paris Cedex 05, France, ITODYS, UMR CNRS 7086, Université Paris VII, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France, and Department of Chemistry, The University of Sheffield, Sheffield, S3 7HF, England
| | - C. Cordier
- Laboratoire de Chimie Inorganique et Matériaux Moléculaires UMR CNRS 7071, Université Pierre et Marie Curie, 4 place Jussieu, case 42, 75252 Paris Cedex 05, France, ITODYS, UMR CNRS 7086, Université Paris VII, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France, and Department of Chemistry, The University of Sheffield, Sheffield, S3 7HF, England
| | - C. Guyard-Duhayon
- Laboratoire de Chimie Inorganique et Matériaux Moléculaires UMR CNRS 7071, Université Pierre et Marie Curie, 4 place Jussieu, case 42, 75252 Paris Cedex 05, France, ITODYS, UMR CNRS 7086, Université Paris VII, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France, and Department of Chemistry, The University of Sheffield, Sheffield, S3 7HF, England
| | - B. E. Mann
- Laboratoire de Chimie Inorganique et Matériaux Moléculaires UMR CNRS 7071, Université Pierre et Marie Curie, 4 place Jussieu, case 42, 75252 Paris Cedex 05, France, ITODYS, UMR CNRS 7086, Université Paris VII, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France, and Department of Chemistry, The University of Sheffield, Sheffield, S3 7HF, England
| | - H. Amouri
- Laboratoire de Chimie Inorganique et Matériaux Moléculaires UMR CNRS 7071, Université Pierre et Marie Curie, 4 place Jussieu, case 42, 75252 Paris Cedex 05, France, ITODYS, UMR CNRS 7086, Université Paris VII, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France, and Department of Chemistry, The University of Sheffield, Sheffield, S3 7HF, England
| |
Collapse
|
25
|
Cordier C, Bencsik A, Philippe S, Bétemps D, Ronzon F, Calavas D, Crozet C, Baron T. Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). J Gen Virol 2006; 87:3763-3771. [PMID: 17098996 DOI: 10.1099/vir.0.82062-0] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Transgenic mice expressing the prion protein (PrP) of species affected by transmissible spongiform encephalopathies (TSEs) have recently been produced to facilitate experimental transmission of these diseases by comparison with wild-type mice. However, whilst wild-type mice have largely been described for the discrimination of different TSE strains, including differentiation of agents involved in bovine spongiform encephalopathy (BSE) and scrapie, this has been only poorly described in transgenic mice. Here, two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59), expressing the ovine PrP (A136 R154 Q171) under control of the neuron-specific enolase promoter, were studied; they were challenged with brainstem or spinal cord from experimentally BSE-infected sheep (AA136 RR154 QQ171 and AA136 RR154 RR171 genotypes) or brainstem from cattle BSE and natural sheep scrapie. The disease was transmitted successfully from all of these sources, with a mean of approximately 300 days survival following challenge with material from two ARQ-homozygous BSE-infected sheep in TgOvPrP4 mice, whereas the survival period in mice challenged with material from the ARR-homozygous BSE-infected sheep was 423 days on average. It was shown that, in the two ovine transgenic mouse lines, the Western blot characteristics of protease-resistant PrP (PrPres) were similar, whatever the BSE source, with a low apparent molecular mass of the unglycosylated glycoform, a poor labelling by P4 monoclonal antibody and high proportions of the diglycosylated form. With all BSE sources, but not with scrapie, florid plaques were observed in the brains of mice from both transgenic lines. These data reinforce the potential of this recently developed experimental model for the discrimination of BSE from scrapie agents.
Collapse
Affiliation(s)
- C Cordier
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - A Bencsik
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - S Philippe
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - D Bétemps
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - F Ronzon
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - D Calavas
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - C Crozet
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - T Baron
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| |
Collapse
|
26
|
Gaudry E, Aubard J, Amouri H, Lévi G, Cordier C. SERRS study of the DNA binding by Ru(II) tris-(Bipyridyl) complexes bearing one carboxylic group. Biopolymers 2006; 82:399-404. [PMID: 16421855 DOI: 10.1002/bip.20435] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Surface enhanced resonance Raman scattering (SERRS) is shown to be a satisfying method to study the interaction between DNA and ruthenium complexes [Ru(bpy)(2)(Hcmbpy)][PF(6)](2), where Hcmbpy = 4-carboxy-4'-methyl-2,2'-bipyridine. Such metallic complexes are known for their fluorescence properties. To validate this spectroscopic approach we have checked that i) at a given lambda(ex), silver colloidal SERRS spectra of Ru complexes closely resemble resonance Raman spectra in aqueous solutions, intensity excepted, and ii) the DNA fragments are not altered when they are adsorbed on the Ag nanoparticles surface. This investigation shows that the intensity of the Ru complexes SERRS spectra is reduced in the presence of DNA, in particular for the specific bands assigned to the Hcmbpy ligand. This collapse demonstrates that the Ru complexes bind DNA through the Hcmbpy moiety, and intercalation is suggested as the binding mode. The DNA binding by the enantiopure Ru complexes (Delta or Lambda) is more efficient than by the racemic complexes.
Collapse
Affiliation(s)
- E Gaudry
- ITODYS, UMR CNRS 7086, Université Paris 7, Denis Diderot, 1 rue Guy de la Brosse, 75005 Paris, France
| | | | | | | | | |
Collapse
|
27
|
Gruselle M, Cordier C, Salmain M, El Amouri H, Guerin C, Vaissermann J, Jaouen G. Electronic and steric factors for elimination reactions in carbenium ions derived from (17.beta.-ethynylestradiol)M2L6 complexes (M2L6 = Co2(CO)6, Mo2Cp2(CO)4). X-ray structure of [Mo2Cp2(CO)4(.mu.-CH.tplbond.CC19H25O)]+ BF4-. Organometallics 2002. [DOI: 10.1021/om00161a031] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Cordier C, Gruselle M, Vaissermann J, Troitskaya LL, Bakhmutov VI, Sokolov VI, Jaouen G. Nature of the stabilization of a carbenium ion adjacent to two organometallic groups. [Mo2Cp2(CO)4(.mu.-FcCHC:C(CH2)2CH3]+, BF4-: x-ray structure and NMR dynamic investigation. Organometallics 2002. [DOI: 10.1021/om00059a054] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Cordier C, Gruselle M, Jaouen G, Bakhmutov VI, Galakhov MV, Troitskaya LL, Sokolov VI. NMR structural and dynamic study of a carbenium ion with a steroidal substituent [Mo2Cp2(CO)4(.mu.-HC:CC19H24O]+BF4-. Organometallics 2002. [DOI: 10.1021/om00053a036] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
30
|
Dodin G, Vandergheynst P, Levoir P, Cordier C, Marcourt L. Fourier and wavelet transform analysis, a tool for visualizing regular patterns in DNA sequences. J Theor Biol 2000; 206:323-6. [PMID: 10988018 DOI: 10.1006/jtbi.2000.2127] [Citation(s) in RCA: 86] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A correlation function that compares each base in a DNA sequence to its various neighbours and which is subsequently processed by Fourier and wavelet transforms has been developed. The procedure has been applied to sequences from the human chromosome 22, to nef genes from various HIV clones and to myosin heavy chain DNA. It permits to readily visualize regular features in DNA which are related to the stability of heteroduplexes formed upon strand slippage.
Collapse
Affiliation(s)
- G Dodin
- ITODYS, associé au CNRS, Université Denis Diderot, Paris, France
| | | | | | | | | |
Collapse
|
31
|
Cordier C, Lemoine M, Lemanceau P, Gianinazzi-Pearson V, Gianinazzi S. THE BENEFICIAL RHIZOSPHERE : A NECESSARY STRATEGY FOR MICROPLANT PRODUCTION. ACTA ACUST UNITED AC 2000. [DOI: 10.17660/actahortic.2000.530.31] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
32
|
Monassier JP, Jacquemin L, Ohlmann P, Zélinsky R, Cordier C, Dallemand R, Lévy J, Panès F, Bischoff N, Laval G. [Angioplasty or surgery in the patient with multivessel disease]. Arch Mal Coeur Vaiss 1999; 92:1617-26. [PMID: 10598244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
The aims of myocardial revascularisation are to treat angina, reduce ischaemia and improve life expectancy. Patients with multivessel disease have a poor prognosis, especially when the lesions are proximal, when the preseptal left anterior descending artery is involved and when left ventricular dysfunction is present. In this particular group of patients, coronary bypass surgery has been shown to improve 10 year survival. Coronary angioplasty has been compared with surgical treatment in many clinical trials. The medium-term survival is the same in both groups, but with a higher number of repeat procedures except in diabetic patients in whom mortality is higher after angioplasty. The use of coronary stents should reduce the number of post-angioplasty procedures. Constant technical improvements, the introduction of surgery without cardiopulmonary bypass, combined revascularisation procedures, new antiplatelet drugs, the absence of long-term comparative results, all this results in a personalized choice of revascularisation procedure based on the overall clinical and angiography features of each particular case.
Collapse
Affiliation(s)
- J P Monassier
- Service de cardiologie, hôpital Emile-Muller, Mulhouse
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Marcourt L, Cordier C, Couesnon T, Dodin G. Impact of C5-cytosine methylation on the solution structure of d(GAAAACGTTTTC)2. An NMR and molecular modelling investigation. Eur J Biochem 1999; 265:1032-42. [PMID: 10518799 DOI: 10.1046/j.1432-1327.1999.00819.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The solution structures of d(GAAAACGTTTTC)2 and of its methylated derivative d(GAAAAMe5CGTTTTC)2 have been determined by NMR and molecular modelling in order to examine the impact of cytosine methylation on the central CpG conformation. Detailed 1H NMR and 31P NMR investigation of the two oligomers includes quantitative NOESY, 2D homonuclear Hartmann-Hahn spectroscopy, double-quantum-filtered COSY and heteronuclear 1H-31P correlation. Back-calculations of NOESY spectra and simulations of double-quantum-filtered COSY patterns were performed to gain accurate information on interproton distances and sugar phase angles. Molecular models under experimental constraints were generated by energy minimization by means of the molecular mechanics program JUMNA. The MORASS software was used to iteratively refine the structures obtained. After methylation, the oligomer still has a B-DNA conformation. However, there are differences in the structural parameters and the thermal stability as compared to the unmethylated molecule. Careful structural analysis shows that after methylation CpG departs from the usual conformation observed in other ACGT tetramers with different surroundings. Subtle displacements of bases, sugars and backbone imposed by the steric interaction of the two methyl groups inside the major groove are accompanied by severe pinching of the minor groove at the C-G residues.
Collapse
Affiliation(s)
- L Marcourt
- Institut de Topologie et de Dynamique des Systèmes, associé au CNRS, Université D. Diderot (Paris 7), Paris, France
| | | | | | | |
Collapse
|
34
|
Cordier C, Marcourt L, Petitjean M, Dodin G. Conformational variation of the central CG site in d(ATGACGTCAT)2 and d(GAAAACGTTTTC)2. An NMR, molecular modelling and 3D-homology investigation. Eur J Biochem 1999; 261:722-33. [PMID: 10215889 DOI: 10.1046/j.1432-1327.1999.00314.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The determination of the solution structure of two self-complementary oligomers d(ATGACGTCAT)2 (CG10) and d(GAAAACGTTTTC)2 (CG12), both containing the 5'-pur-ACGT-pyr-3' sequence, is reported. The impact of the base context on the conformation of the central CpG site has been examined by a combined approach of: (a) 2D 1H-NMR and 31P-NMR; (b) molecular mechanics under experimental constraints; (c) back-calculations of NOESY spectra and iterative refinements of distances; and (d) 3D-homology search of the central tetrad ACGT within the complete oligonucleotides. A full NMR study of each fragment is achieved by means of standard 2D experiments: NOESY, 2D homonuclear Hartmann-Hahn spectroscopy, double-quantum-filtered COSY and heteronuclear 1H-31P correlation. Sugar phase angle, epsilon-zeta difference angle and NOE-derived distances are input as experimental constraints to generate molecular models by energy minimization with the help of jumna. The morass program is used to iteratively refine the structures obtained. The similarity of the two ACGTs within the whole oligonucleotides is investigated. Both the decamer and the dodecamer adopt a B-like DNA conformation. However, the helical parameters within this conformational type are significantly different in CG12 and CG10. The central CpG step conformation is not locked by its nearest environment (5'A and 3'T) as seen from the structural analysis of ACGT in the two molecules. In CG12, despite the presence of runs of A-T pairs, CpG presents a high twist of 43 degrees and a sugar phase at the guanine of about 180 degrees, previously observed in other ACGT-containing-oligomers. Conversely, ACGT in CG10 exhibits strong inclinations, positive rolls, a flat profile of sugar phase, twist and glycosidic angles, as a result of the nucleotide sequence extending beyond the tetrad. The structural specificity of CG10 and its flexibility (as reflected by its energy) are tentatively related to the process of recognition of the cyclic AMP response element by its cognate protein.
Collapse
Affiliation(s)
- C Cordier
- Institut de Topologie et de Dynamique des Systèmes, associé au CNRS, Université D. Diderot (Paris 7), France
| | | | | | | |
Collapse
|
35
|
Boughriet A, Ouddane B, Cordier C, Laureyns J. Thermodynamic, spectroscopic and magnetic studies on anoxic sediments from the Seine river estuary. ACTA ACUST UNITED AC 1998. [DOI: 10.1039/a805988h] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
36
|
|
37
|
Cordier C, Trouvelot A, Gianinazzi S, Gianinazzi-Pearson V. Arbuscular mycorrhiza technology applied to micropropagated Prunus avium and to protection against Phytophthora cinnamomi. ACTA ACUST UNITED AC 1996. [DOI: 10.1051/agro:19961013] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
38
|
Pozo MJ, Dumas-Gaudot E, Slezack S, Cordier C, Asselin A, Gianinazzi S, Gianinazzi-Pearson V, Azcón-Aguilar C, Barea JM. Induction of new chitinase isoforms in tomato roots during interactions with Glomus mosseae and/or Phytophthora nicotianae var parasitica. ACTA ACUST UNITED AC 1996. [DOI: 10.1051/agro:19961014] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
39
|
Boughriet A, Cordier C, Deram L, Ouddane B, Chamley H, Wartel M. Coprecipitation/accumulation/distribution of manganese and iron, and electrochemical characteristics of Mn in calcareous seawater. ACTA ACUST UNITED AC 1995. [DOI: 10.1007/bf00322231] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Gruselle M, Cordier C, Salmain M, El Amouri H, Guerin C, Vaissermann J, Jaouen G. Electronic and steric factors for elimination reactions in carbenium ions derived from (17.beta.-ethynylestradiol)M2L6 complexes (M2L6 = Co2(CO)6, Mo2Cp2(CO)4. X-ray structure of [Mo2Cp2(CO)4(.mu.-CH.tplbond.CC19H25O)]+BF-4 [Erratum to document cited in CA113(23):212426v]. Organometallics 1991. [DOI: 10.1021/om00049a056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Troitskaya L, Sokolov V, Bakhmutov V, Reutov O, Gruselle M, Cordier C, Jaouen G. Stabilisation of carbenium ions species by two different adjacent organometallic moieties: synthesis, NMR study and synthetic application. J Organomet Chem 1989. [DOI: 10.1016/0022-328x(89)85343-4] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|